Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2014 Apr 29;11117:E1759-67. doi: 10.1073/pnas.1322965111.
Show Gene links
Show Anatomy links
Diverse mutational pathways converge on saturable chloroquine transport via the malaria parasite's chloroquine resistance transporter.
Summers RL
,
Dave A
,
Dolstra TJ
,
Bellanca S
,
Marchetti RV
,
Nash MN
,
Richards SN
,
Goh V
,
Schenk RL
,
Stein WD
,
Kirk K
,
Sanchez CP
,
Lanzer M
,
Martin RE
.
???displayArticle.abstract???
Mutations in the chloroquine resistance transporter (PfCRT) are the primary determinant of chloroquine (CQ) resistance in the malaria parasite Plasmodium falciparum. A number of distinct PfCRT haplotypes, containing between 4 and 10 mutations, have given rise to CQ resistance in different parts of the world. Here we present a detailed molecular analysis of the number of mutations (and the order of addition) required to confer CQ transport activity upon the PfCRT as well as a kinetic characterization of diverse forms of PfCRT. We measured the ability of more than 100 variants of PfCRT to transport CQ when expressed at the surface of Xenopus laevis oocytes. Multiple mutational pathways led to saturable CQ transport via PfCRT, but these could be separated into two main lineages. Moreover, the attainment of full activity followed a rigid process in which mutations had to be added in a specific order to avoid reductions in CQ transport activity. A minimum of two mutations sufficed for (low) CQ transport activity, and as few as four conferred full activity. The finding that diverse PfCRT variants are all limited in their capacity to transport CQ suggests that resistance could be overcome by reoptimizing the CQ dosage.
Allen,
Plasmodium falciparum culture: the benefits of shaking.
2010, Pubmed
Allen,
Plasmodium falciparum culture: the benefits of shaking.
2010,
Pubmed
Bergeron,
Frog oocytes to unveil the structure and supramolecular organization of human transport proteins.
2011,
Pubmed
,
Xenbase
Bray,
PfCRT and the trans-vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX.
2006,
Pubmed
Bröer,
Comparison of lactate transport in astroglial cells and monocarboxylate transporter 1 (MCT 1) expressing Xenopus laevis oocytes. Expression of two different monocarboxylate transporters in astroglial cells and neurons.
1997,
Pubmed
,
Xenbase
Bröer,
Xenopus laevis Oocytes.
2010,
Pubmed
,
Xenbase
Burrows,
Designing the next generation of medicines for malaria control and eradication.
2013,
Pubmed
Chaijaroenkul,
Sequence and gene expression of chloroquine resistance transporter (pfcrt) in the association of in vitro drugs resistance of Plasmodium falciparum.
2011,
Pubmed
Chandra,
Creative solutions to extraordinary challenges in clinical trials: methodology of a phase III trial of azithromycin and chloroquine fixed-dose combination in pregnant women in Africa.
2013,
Pubmed
Cooper,
Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum.
2002,
Pubmed
Crabb,
Transfection of the human malaria parasite Plasmodium falciparum.
2004,
Pubmed
Dondorp,
Artemisinin resistance: current status and scenarios for containment.
2010,
Pubmed
Dubar,
The antimalarial ferroquine: role of the metal and intramolecular hydrogen bond in activity and resistance.
2011,
Pubmed
Durrand,
Variations in the sequence and expression of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) and their relationship to chloroquine resistance in vitro.
2004,
Pubmed
Ecker,
Tricks in Plasmodium's molecular repertoire--escaping 3'UTR excision-based conditional silencing of the chloroquine resistance transporter gene.
2012,
Pubmed
Ferdig,
Dissecting the loci of low-level quinine resistance in malaria parasites.
2004,
Pubmed
Fidock,
Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance.
2000,
Pubmed
Fidock,
Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil.
1997,
Pubmed
Fitch,
Chloroquine resistance in malaria: a deficiency of chloroquine binding.
1969,
Pubmed
Giglioli,
Interruption of malaria transmission by chloroquinized salt in Guyana, with observations on a chloroquine-resistant strain of Plasmodium falciparum.
1967,
Pubmed
Harms,
Evolutionary biochemistry: revealing the historical and physical causes of protein properties.
2013,
Pubmed
Hayward,
The pH of the digestive vacuole of Plasmodium falciparum is not associated with chloroquine resistance.
2006,
Pubmed
Issaka,
Ex vivo responses of Plasmodium falciparum clinical isolates to conventional and new antimalarial drugs in Niger.
2013,
Pubmed
Jencks,
Binding energy, specificity, and enzymic catalysis: the circe effect.
1975,
Pubmed
Klonis,
Evaluation of pH during cytostomal endocytosis and vacuolar catabolism of haemoglobin in Plasmodium falciparum.
2007,
Pubmed
Kofoed,
Different doses of amodiaquine and chloroquine for treatment of uncomplicated malaria in children in Guinea-Bissau: implications for future treatment recommendations.
2007,
Pubmed
Krogstad,
Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance.
1987,
Pubmed
Kublin,
Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi.
2003,
Pubmed
Kuhn,
Quantitative pH measurements in Plasmodium falciparum-infected erythrocytes using pHluorin.
2007,
Pubmed
Kuhn,
Trafficking of the phosphoprotein PfCRT to the digestive vacuolar membrane in Plasmodium falciparum.
2010,
Pubmed
Lakshmanan,
A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance.
2005,
Pubmed
Lambros,
Synchronization of Plasmodium falciparum erythrocytic stages in culture.
1979,
Pubmed
Mallick,
Mutant pfcrt "SVMNT" haplotype and wild type pfmdr1 "N86" are endemic in Plasmodium vivax dominated areas of India under high chloroquine exposure.
2012,
Pubmed
Martin,
Chloroquine transport via the malaria parasite's chloroquine resistance transporter.
2009,
Pubmed
,
Xenbase
Mok,
Structural polymorphism in the promoter of pfmrp2 confers Plasmodium falciparum tolerance to quinoline drugs.
2014,
Pubmed
Mu,
Multiple transporters associated with malaria parasite responses to chloroquine and quinine.
2003,
Pubmed
Nilsen,
Quinolone-3-diarylethers: a new class of antimalarial drug.
2013,
Pubmed
PINOTTI,
[New method for the control of malaria by the use of drugs mixed with kitchen salt in daily diet].
1953,
Pubmed
Reed,
Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum.
2000,
Pubmed
SINGH,
The superiority of "camoquin" over other antimalarials.
1952,
Pubmed
Sa,
Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the PfCRT SVMNT type.
2010,
Pubmed
Sanchez,
Trans stimulation provides evidence for a drug efflux carrier as the mechanism of chloroquine resistance in Plasmodium falciparum.
2003,
Pubmed
Schneider,
NIH Image to ImageJ: 25 years of image analysis.
2012,
Pubmed
Sidhu,
Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations.
2002,
Pubmed
Sidhu,
pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum.
2005,
Pubmed
Sirois,
Caspase-3-dependent export of TCTP: a novel pathway for antiapoptotic intercellular communication.
2011,
Pubmed
Summers,
Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.
2012,
Pubmed
Sá,
Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine.
2009,
Pubmed
Ursing,
Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.
2011,
Pubmed
Ursing,
Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau.
2007,
Pubmed
Ursing,
Chloroquine resistant P. falciparum prevalence is low and unchanged between 1990 and 2005 in Guinea-Bissau: an effect of high chloroquine dosage?
2007,
Pubmed
Waller,
Chloroquine resistance modulated in vitro by expression levels of the Plasmodium falciparum chloroquine resistance transporter.
2003,
Pubmed
Wang,
Naphthoquine phosphate and its combination with artemisinine.
2004,
Pubmed
Wang,
Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China.
2005,
Pubmed
Welinder,
Coomassie staining as loading control in Western blot analysis.
2011,
Pubmed
Yang,
Molecular analysis of chloroquine resistance in Plasmodium falciparum in Yunnan Province, China.
2007,
Pubmed
Yuan,
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
2011,
Pubmed
Zheng,
An efficient one-step site-directed and site-saturation mutagenesis protocol.
2004,
Pubmed
